Supplier Type
- contract manufacturer
- custom synthesis
- Trader
- Manufacturer
- Reagent
Supplier Region
- Hyderabad(4)
- Maharashtra(9)
- Vadodara(3)
- Gujarat(7)
- Mumbai(19)
- Ahmedabad(2)
- Kolkata(1)
- Delhi(4)
- West Bengal(1)
- Andhra Pradesh(1)
- Punjab(1)
- New Delhi(1)
- Tamil Nadu(1)
Purity
- NLT 95%
- 99.99%
- >99.9%
- 99%
- 98.5%
- 98%
- 96%
- 85% DYE CONTENT
- 25.0 - 50.0 %
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
-
Imatinib
152459-95-5
-
Imatinib mesylate
220127-57-1
-
4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide
404844-11-7
-
iMatinib related substance C
938082-57-6
-
Medicine Grade Imatinib Mesylate Capsules
-
1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one
55314-16-4
-
Bismuth citrate
813-93-4
-
BISMUTH OXYCHLORIDE
7787-59-9
-
Chromium(III) oxide
1308-38-9
-
Iridium trichloride
10025-83-9
Imatinib 152459-95-5
contract manufacturer
custom synthesis
Contract Research
Imatinib 152459-95-5
Trader
Imatinib mesylate 220127-57-1
Trader
Imatinib mesylate 220127-57-1
Trader
Manufacturer
Note:Purity: NLT 95% | Package: 25 MG 50 MG 100 MG 250 MG EXTRA
4Y
Hyderabad
Product catalog:
1000
Mumbai
Product catalog:
125
Ahmedabad
Product catalog:
109
Maharashtra
Product catalog:
33
96% Imatinib EP Impurity A, 25mg,50mg,100mg., Lab Grade 55314-16-4
Reagent
Note:Purity: 96% | Package: 1mg;
Mumbai
Product catalog:
181